Finding | Â | Number of women/total | % |
---|---|---|---|
Body mass index | < 18 kg/m2 | 26/1117 | 2.3 |
 | 18-25 kg/m2 | 390/1117 | 34.9 |
 | 25-30 kg/m2 | 426/1117 | 38.2 |
 | > 30 kg/m2 | 275/1117 | 24.6 |
Inspecting perineum | Inflammation | 98/967 | 10.1 |
 | Purulent vaginal discharge | 159/967 | 16.4 |
 | Ulcer | 5/967 | 0.5 |
 | Wart | 2/967 | 0.2 |
Speculum examination | Mucopurulent cervical discharge | 169/967 | 17.5 |
 | Cervix bleed on touching | 32/967 | 3.3 |
 | Cervical inflammation | 107/967 | 11.1 |
 | Cervical laceration | 43/967 | 4.4 |
 | Cervical polyp | 6/967 | 0.6 |
*Reproductive tract infections | Using specific definition | 364/967 | 37.6%(95% CI 34.5-40.7) |
Pelvic organ prolapse | Stage 1 | 296/967 | 30.6 |
 | Stage 2 | 77/967 | 8.0 |
 | Sage 3 | 24/967 | 2.5 |
 | Stage 4 | 3/967 | 0.3 |
**Total Pelvic organ prolapse | Using specific definition | 391/967 | 41.4(95% CI 39.8- 44.5) |
Bimanual pelvic examination | Cervical motion tenderness | 60/967 | 6.2 |
 | Uterus enlarged | 42/967 | 4.3 |
 | Uterine fibroid | 9/967 | 0.9 |
 | Adnexal mass | 21/967 | 2.2 |
 | Total Pelvic mass correctly diagnosed | 14/929 | 1.5(95% CI 0.7-2.3) |
Ultrasonographic findings | Uterus enlarged | 108/929 | 11.2 |
 | Endometrial Polyp | 4/929 | 0.4 |
 | Polycystic ovaries | 156/929 | 16.8 |
 | Uterine fibroid | 33/929 | 3.6 |
 | Adnexal mass | 38/929 | 4.1 |
 | Total Pelvic mass | 71/929 | 7.6(95% CI: 5.9-9.3) |